France· FR:64670426
ATECTURA BREEZHALER 125 microgrammes/127,5 microgrammes, poudre pour inhalation en gélule
A medicinal product containing furoate de mométasone + acétate d'indacatérol, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- FUROATE DE MOMÉTASONE + ACÉTATE D'INDACATÉROL
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip133400930207758plaquette(s) unidose(s) polyamide aluminium PVC-Aluminium de 10 x 1 gélule (en dose unitaire) + 1 inhalateur
- cip133400930207772plaquette(s) unidose(s) polyamide aluminium PVC-Aluminium de 30 x 1 gélule (en dose unitaire) + 1 inhalateurEUR 22.67
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Furoate de mométasone + acétate d'indacatérol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATECTURA BREEZHALERNovartis Europharm Limited, Dublin
- SpainATECTURA BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- SwedenAtectura Breezhaler 125 mikrogram/127,5 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- SwitzerlandAtectura Breezhaler
- IcelandAtectura BreezhalerNovartis Europharm Limited*
- IrelandAtectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Atectura Breezhaler, Bemrist Breezhaler
- Liechtenstein · Atectura Breezhaler, Bemrist Breezhaler
- Norway · Atectura Breezhaler, Bemrist Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dae94415-ce03-4d04-b319-ea4bb7b10035 GET /v1/drugs/dae94415-ce03-4d04-b319-ea4bb7b10035?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64670426",
"date_amm": "2020-05-30",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1439",
"substance": "FUROATE DE MOMÉTASONE + ACÉTATE D'INDACATÉROL",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour inhalation en gélule",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about furoate de mométasone + acétate d'indacatérol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.